Anyone looking for negatives in this announcement are classic glass half empty people. These results to date are extremely encouraging. They are already getting very accurate results (look at that clustering diagram) and as we know AI only gets better with more data. Significantly de-risked.
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability, page-10
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.00 |
Change
0.000(0.00%) |
Mkt cap ! $171.0M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.05 | $1.99 | $107.6K | 53.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2710 | $1.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.06 | 2346 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| EMV (ASX) Chart |